AMEX · Financial Statements

Xtant Medical Holdings, Inc. (XTNT) Financial Statements

$0.28 AMEX: XTNT Market Cap $39.60M

Xtant Medical Holdings, Inc. most recently reported annual revenue of $134.0M, net profit of $5.0M. Revenue grew at an average annual rate of 20.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Xtant Medical Holdings, Inc.: Revenue rose from $90.0M in 2016 to $134.0M in 2025, a change of +48.9% over 9 years; net profit was positive in 2 of 10 reported years; operating margin moved from -8.4% to 5.4%, a shift of +13.8 percentage points; the most recent year shows net profit of $5.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$90.0M$83.0M$72.0M$65.0M$53.0M$55.0M$58.0M$91.0M$117.0M$134.0M
Operating Expenses$98.0M$120.0M$132.0M$67.0M$54.0M$59.0M$65.0M$101.0M$129.0M$127.0M
Operating Profit$-8.0M$-38.0M$-60.0M$-2.0M$-1.0M$-4.0M$-7.0M$-10.0M$-12.0M$7.0M
Operating Margin-8.4%-45.8%-83.2%-3.6%-1.4%-7.0%-11.7%-11.1%-10.3%5.4%
Other Income$-12.0M$-15.0M$-10.0M$-6.0M$-6.0M$-1.0M$-2.0M$9.0M$-4.0M$0
Interest$12.0M$15.0M$10.0M$6.0M$6.0M$1.0M$2.0M$3.0M$4.0M$4.0M
Depreciation$7.0M$8.0M$6.0M$3.0M$2.0M$1.0M$1.0M$3.0M$4.0M$5.0M
Profit Before Tax$-19.0M$-52.0M$-70.0M$-8.0M$-7.0M$-5.0M$-8.0M$-1.0M$-16.0M$7.0M
Tax$-260,000$0$-180,000$-1.2M$-4.4M$0$-820,000$163.7M$-1.1M$29.0M
Net Profit$-19.0M$-52.0M$-70.0M$-8.0M$-7.0M$-5.0M$-8.0M$1.0M$-16.0M$5.0M
EPS$-18.32$-34.51$-5.93$-0.62$-0.25$-0.06$-0.09$0.01$-0.12$0.03
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$25.0M$28.0M$28.0M$30.0M$28.0M$32.0M$33.0M$35.0M$33.0M$32.0M$21.0M$23.0M
Operating Expenses$28.0M$32.0M$31.0M$33.0M$32.0M$33.0M$32.0M$31.0M$31.0M$33.0M$24.0M$32.0M
Operating Profit$-3.0M$-4.0M$-3.0M$-3.0M$-4.0M$-2.0M$1.0M$5.0M$3.0M$-1.0M$-3.0M$-9.0M
Operating Margin-13.5%-13.5%-12.4%-9.8%-13.5%-6.0%3.2%13.1%7.6%-2.9%-14.0%-39.8%
Interest$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M
Profit Before Tax$7.0M$-4.0M$-4.0M$-4.0M$-5.0M$-3.0M$0$4.0M$2.0M$2.0M$-3.0M$-9.0M
Tax$-33.2M$-15.5M$-1.6M$-940,000$-1.3M$-670,000$-75.8M$6.7M$16.4M$96.4M$-880,000$-780,000
Net Profit$9.0M$-4.0M$-4.0M$-4.0M$-5.0M$-3.0M$0$4.0M$1.0M$0$-3.0M$-9.0M
EPS$0.07$-0.03$-0.03$-0.03$-0.04$-0.02$0.00$0.02$0.01$0.00$-0.02$-0.07

Over the 10 years reported for Xtant Medical Holdings, Inc., borrowings decreased from $131.0M in 2016 to $29.0M in 2025, cash stood at $17.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.69 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$144.0M$106.0M$46.0M$43.0M$41.0M$55.0M$60.0M$93.0M$94.0M$94.0M
Current Assets$49.0M$40.0M$35.0M$32.0M$31.0M$44.0M$49.0M$65.0M$67.0M$78.0M
Cash$3.0M$3.0M$7.0M$5.0M$2.0M$18.0M$20.0M$6.0M$6.0M$17.0M
Inventory$26.0M$22.0M$17.0M$16.0M$21.0M$18.0M$17.0M$37.0M$39.0M$30.0M
Receivables$19.0M$13.0M$10.0M$10.0M$7.0M$7.0M$11.0M$21.0M$21.0M$18.0M
Fixed Assets$16.0M$10.0M$7.0M$7.0M$6.0M$6.0M$7.0M$10.0M$11.0M$9.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0$0$0
Other Assets$42.0M$42.0M$3.0M$3.0M$3.0M$3.0M$3.0M$7.0M$7.0M$6.0M
Total Liabilities$151.0M$164.0M$90.0M$87.0M$27.0M$24.0M$26.0M$41.0M$51.0M$43.0M
Current Liabilities$31.0M$26.0M$12.0M$9.0M$26.0M$11.0M$15.0M$23.0M$29.0M$29.0M
Borrowings$131.0M$139.0M$79.0M$79.0M$19.0M$17.0M$17.0M$24.0M$35.0M$29.0M
Other Liabilities$20.0M$25.0M$12.0M$9.0M$8.0M$7.0M$9.0M$18.0M$16.0M$14.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$-7.0M$-59.0M$-44.0M$-44.0M$15.0M$31.0M$34.0M$51.0M$43.0M$51.0M

For Xtant Medical Holdings, Inc., operating cash flow was positive in 2 of 10 reported years; free cash flow in the latest year was $10.0M; free cash flow was positive in 2 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$-14.0M$-1.0M$1.0M$0$-1.0M$0$-5.0M$-10.0M$-12.0M$13.0M
Investing Cash Flow$-12.0M$-3.0M$-1.0M$-1.0M$-3.0M$-4.0M$-3.0M$-26.0M$-8.0M$6.0M
Financing Cash Flow$10.0M$0$-3.0M$0$-1.0M$0$0$0$-1.0M$0
Net Cash Flow$-4.0M$0$4.0M$-2.0M$-3.0M$16.0M$2.0M$-15.0M$0$11.0M
Free Cash Flow$-20.0M$-2.0M$1.0M$-1.0M$-2.0M$-2.0M$-7.0M$-11.0M$-16.0M$10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-26.07
FCF Yield-1.45%
Quick Ratio1.05
Interest Coverage-3.80
Return 1Y-28.23%
Return 3Y-50.00%
Return 5Y-65.50%

Xtant Medical Holdings, Inc. (XTNT) financials — frequently asked questions

What is Xtant Medical Holdings, Inc.'s annual revenue?

Xtant Medical Holdings, Inc. (XTNT) reported annual revenue of $134.0M in its most recent fiscal year.

What is Xtant Medical Holdings, Inc.'s net profit?

Xtant Medical Holdings, Inc. (XTNT) reported net profit of $5.0M in its most recent fiscal year.

What is XTNT EV/EBITDA?

Xtant Medical Holdings, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -26.07. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
XTNT Overview XTNT Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.